Co-administration of cyclosporin enables oral therapy with paclitaxel

An ultra-sensitive liquid chromatography tandem mass spectrometry method for the simultaneous quantification of 2H6-alectinib and alectinib in human plasma to support a microtracer food-effect trial.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2025

Development of a UPLC-MS/MS Assay for the Quantitative Determination of Capecitabine, 5'-deoxy-5-fluorocytidine (5'-dFCR), 5'-deoxy-5-fluorouridine (5'-dFUR), 5'-fluorouracil (5-FU), and α-fluoro-β-alanine (FBAL).

Die Pharmazie·2023

Exposure-response analyses of BRAF- and MEK-inhibitors dabrafenib plus trametinib in melanoma patients.

Cancer chemotherapy and pharmacology·2023

Therapeutic drug monitoring-based precision dosing of oral targeted therapies in oncology: a prospective multicenter study.

Annals of oncology : official journal of the European Society for Medical Oncology·2022

A highly sensitive bioanalytical method for the quantification of vinblastine, vincristine, vinorelbine and 4-O-deacetylvinorelbine in human plasma using LC-MS/MS.

Journal of pharmaceutical and biomedical analysis·2022

Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients.

Drug metabolism and disposition: the biological fate of chemicals·2022

Faecal microbiota transplantation in irritable bowel syndrome (REFIT2): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Understanding peripheral arterial disease in the current era.

Lancet (London, England)·2026

Current advancements in the care of peripheral arterial disease: modern approaches to medical, endovascular, and surgical treatment.

Lancet (London, England)·2026

Peripheral arterial disease: adverse impacts, disparities in outcomes, and the path ahead.

Lancet (London, England)·2026

Developing roadmaps for advancing practice, research, and policy in the arts and health.

Lancet (London, England)·2026

Cellular and molecular mechanisms determining allogeneic CAR T cell rejection and expansion.

Cancer discovery·2026

Clinical and scintigraphic improvement of mandibular involvement associated with chronic nonbacterial osteitis following an interleukin-23 inhibitor: a case-based literature review.

Immunological medicine·2026

Navigating clozapine discontinuation in clinical practice: An updated framework.

Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists·2026

Early progression after immune checkpoint inhibitor therapy in recurrent or metastatic head and neck squamous cell carcinoma: association with disease distribution in a single-center retrospective study.

Japanese journal of clinical oncology·2026

Evaluation of the protective effects of green tea for ischemia-reperfusion injury in rat ovary tissue: an experimental study.

Acta cirurgica brasileira·2026

Early intervention with clozapine: Is there a neurobiological critical period for treatment-resistant schizophrenia?

Journal of psychopharmacology (Oxford, England)·2026

Related Experiment Videos

Co-administration of cyclosporin enables oral therapy with paclitaxel

Related Concept Videos

An ultra-sensitive liquid chromatography tandem mass spectrometry method for the simultaneous quantification of 2H6-alectinib and alectinib in human plasma to support a microtracer food-effect trial.

Development of a UPLC-MS/MS Assay for the Quantitative Determination of Capecitabine, 5'-deoxy-5-fluorocytidine (5'-dFCR), 5'-deoxy-5-fluorouridine (5'-dFUR), 5'-fluorouracil (5-FU), and α-fluoro-β-alanine (FBAL).

Exposure-response analyses of BRAF- and MEK-inhibitors dabrafenib plus trametinib in melanoma patients.

Therapeutic drug monitoring-based precision dosing of oral targeted therapies in oncology: a prospective multicenter study.

A highly sensitive bioanalytical method for the quantification of vinblastine, vincristine, vinorelbine and 4-O-deacetylvinorelbine in human plasma using LC-MS/MS.

Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients.

Faecal microbiota transplantation in irritable bowel syndrome (REFIT2): a randomised, double-blind, placebo-controlled, phase 3 trial.

Understanding peripheral arterial disease in the current era.

Current advancements in the care of peripheral arterial disease: modern approaches to medical, endovascular, and surgical treatment.

Peripheral arterial disease: adverse impacts, disparities in outcomes, and the path ahead.

Developing roadmaps for advancing practice, research, and policy in the arts and health.

Cellular and molecular mechanisms determining allogeneic CAR T cell rejection and expansion.

Clinical and scintigraphic improvement of mandibular involvement associated with chronic nonbacterial osteitis following an interleukin-23 inhibitor: a case-based literature review.

Navigating clozapine discontinuation in clinical practice: An updated framework.

Early progression after immune checkpoint inhibitor therapy in recurrent or metastatic head and neck squamous cell carcinoma: association with disease distribution in a single-center retrospective study.

Evaluation of the protective effects of green tea for ischemia-reperfusion injury in rat ovary tissue: an experimental study.

Early intervention with clozapine: Is there a neurobiological critical period for treatment-resistant schizophrenia?

Related Experiment Videos

Co-administration of cyclosporin enables oral therapy with paclitaxel

Related Concept Videos

Related Articles